StockTipsArenaBeta

BUY Alkem Laboratories Limited — Jefferies India

BUYAlkem Laboratories Limited
Alkem Laboratories share price target & all analyst calls

byJefferies IndiaHorizon: NA (inferred 1 year)13 Nov 2026via Zee Business (Live)

Entry₹5,300Inferred
Target₹6,520
Total upside +23.02%
Stop lossNot given
CMP₹5,1141d ago
Active-3.51%+27.49%upside left 12 mo left
Follow Jefferies India for new calls(99% target hit, 73 closed calls)Get alertsWatch ALKEM for new buy/sell callsGet alertsSee 6 other Long-term calls on ALKEMSee 272 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Nov, 3:34 am IST
7 supporting6 neutral3 opposing
Supports the BUY call (7)

Alkem Laboratories reported consolidated revenue from operations of Rs 45,519.9 million and a profit for the period of Rs 6,671.3 million for the quarter ended September 30, 2026.

BSE · Board Meeting·12 Nov · 2d ago

(opens in new tab)

Alkem Laboratories has appointed Dr. Amrut Naik as the new Chief Executive Officer (CEO) and Key Managerial Personnel.

BSE · Company Update·3 Nov · 2w ago

(opens in new tab)

The US FDA concluded an inspection of Alkem Laboratories' API manufacturing facility in Mandva with no Form 483 observations.

BSE · Company Update·30 Oct · 2w ago

(opens in new tab)

4 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·7 Oct · 1mo ago

Neutral / worth noting (6)

The company has appointed Mr. Gopal Kothari as the new CFO and KMP effective December 2, 2026.

BSE · Company Update·12 Nov · 2d ago

(opens in new tab)

Alkem Laboratories Limited has appointed Mr. Gopal Kothari as the new Chief Financial Officer, effective December 02, 2026.

NSE · Appointment·12 Nov · 2d ago

(opens in new tab)

Alkem Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·12 Nov · 2d ago

(opens in new tab)
Weighs against the BUY call (3)

Long-term trend bearish — 200-day average falling over the past quarter

Technicals · trend·13 Nov · yesterday

Alkem Laboratories Q2 Results: Net Profit Falls 12% To Rs 675 Crore; Ropes In Gopal Kothari As CFO

NewsNdtv-Profit·12 Nov · 2d ago

(opens in new tab)

1 other SEBI-registered advisor has an active long-term SELL call on this stock

Advisor consensus · same horizon·14 Aug · 3mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Alkem Laboratories

All analyst calls on Alkem Laboratories

More from Jefferies India

Every call and its outcome